BioStem Technologies Chief Commercial Officer Hassett Barry exercised Options for 500 shares at $0 per share, leaving him with 5,003 shares and 4,497 derivative securities. The transaction represented about 10.0% of the resulting share holding and about 10.0% of the prior derivative-securities holding, giving investors the disclosed ownership context.
Key Highlights
- Hassett Barry’s exercise represented about 10.0% of his resulting share holding.
- The transaction used code M, the classification for an option exercise.
- Barry’s prior derivative-securities holding was represented by a transaction equal to about 10.0%.
BioStem Technologies, Inc. (NASDAQ: BSEM) Chief Commercial Officer Hassett Barry exercised options for 500 shares at $0 per share on Sep 9, 2026. The same transaction covered 500 derivative securities.
Option Exercise Leaves Separate Holdings Barry held 5,003 shares after the transaction.
He also owned 4,497 derivative securities following the exercise. The share and derivative-security figures are reported separately. The exercise price for the shares was $0 per share.
transaction represented about 10.0% of Barry’s resulting share holding. Separately, it represented about 10.0% of his prior derivative-securities holding. Those percentages apply to different categories, with the first tied to shares held after the transaction and the second tied to derivative securities held before it.
FAQs
Q: What did Hassett Barry exercise at BioStem Technologies?
A: Hassett Barry exercised options for 500 BioStem Technologies shares at $0 per share. The transaction also covered 500 derivative securities on Sep 9, 2026.
Q: How did the BioStem Technologies transaction affect Barry’s holdings?
A: Barry owned 5,003 shares after the option exercise. He also held 4,497 derivative securities following the transaction, according to the disclosed ownership figures.
Q: What does the 10.0% figure mean for BSEM investors?
A: The 10.0% figure applies separately to two ownership bases. It represents the resulting share holding for one measure and the prior derivative-securities holding for the other.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.